Ieq Capital LLC Makes New $1.75 Million Investment in Sotera Health Company $SHC

Ieq Capital LLC purchased a new stake in Sotera Health Company (NASDAQ:SHC) during the 2nd quarter, Holdings Channel.com reports. The firm purchased 98,446 shares of the company’s stock, valued at approximately $1,747,000.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Allworth Financial LP acquired a new stake in Sotera Health in the 2nd quarter valued at approximately $262,000. West Family Investments Inc. acquired a new position in Sotera Health during the 2nd quarter worth approximately $225,000. Meeder Asset Management Inc. bought a new position in shares of Sotera Health during the 2nd quarter worth approximately $37,000. Citizens Financial Group Inc. RI bought a new position in shares of Sotera Health during the 2nd quarter worth approximately $242,000. Finally, BlackRock Inc. acquired a new stake in shares of Sotera Health in the second quarter valued at approximately $428,635,000. 91.03% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Sotera Health

In other Sotera Health news, insider Michael P. Rutz sold 150,000 shares of the company’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $18.84, for a total value of $2,826,000.00. Following the sale, the insider owned 334,279 shares in the company, valued at $6,297,816.36. This represents a 30.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the completion of the sale, the chairman directly owned 3,969,393 shares of the company’s stock, valued at approximately $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,294,515 shares of company stock valued at $23,999,528 in the last quarter. 15.36% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of analysts have recently commented on SHC shares. Barclays boosted their price objective on shares of Sotera Health from $19.00 to $22.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. JPMorgan Chase & Co. lifted their price target on shares of Sotera Health from $16.00 to $18.00 and gave the company a “neutral” rating in a research note on Friday, August 7th. The Goldman Sachs Group assumed coverage on shares of Sotera Health in a research report on Friday, June 5th. They set a “buy” rating and a $20.00 price target on the stock. UBS Group set a $19.00 price objective on shares of Sotera Health in a research note on Wednesday, June 24th. Finally, Citigroup raised their price objective on Sotera Health from $23.00 to $25.00 and gave the company a “buy” rating in a report on Friday, August 7th. Eight investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $21.50.

Sotera Health Stock Performance

NASDAQ SHC opened at $19.51 on Wednesday. The firm has a market capitalization of $5.57 billion, a P/E ratio of 34.23 and a beta of 1.77. The company has a current ratio of 2.80, a quick ratio of 2.55 and a debt-to-equity ratio of 3.33. The firm’s fifty day moving average price is $17.89 and its two-hundred day moving average price is $16.36. Sotera Health Company has a 1 year low of $13.09 and a 1 year high of $19.85.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. The company had revenue of $321.38 million during the quarter, compared to the consensus estimate of $309.70 million. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The company’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.20 EPS. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, research analysts anticipate that Sotera Health Company will post 0.86 EPS for the current year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.